These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35099571)

  • 21. PD-L1 Checkpoint Inhibition Narrows the Antigen-Specific T Cell Receptor Repertoire in Chronic Lymphocytic Choriomeningitis Virus Infection.
    Klein S; Ghersi D; Manns MP; Prinz I; Cornberg M; Kraft ARM
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors.
    Duraiswamy J; Kaluza KM; Freeman GJ; Coukos G
    Cancer Res; 2013 Jun; 73(12):3591-603. PubMed ID: 23633484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PD-L1 enhances CNS inflammation and infarct volume following experimental stroke in mice in opposition to PD-1.
    Bodhankar S; Chen Y; Vandenbark AA; Murphy SJ; Offner H
    J Neuroinflammation; 2013 Sep; 10():111. PubMed ID: 24015822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wide Expression and Significance of Alternative Immune Checkpoint Molecules, B7x and HHLA2, in PD-L1-Negative Human Lung Cancers.
    Cheng H; Borczuk A; Janakiram M; Ren X; Lin J; Assal A; Halmos B; Perez-Soler R; Zang X
    Clin Cancer Res; 2018 Apr; 24(8):1954-1964. PubMed ID: 29374053
    [No Abstract]   [Full Text] [Related]  

  • 25. Circulating HLA-DR+CD4+ effector memory T cells resistant to CCR5 and PD-L1 mediated suppression compromise regulatory T cell function in tuberculosis.
    Ahmed A; Adiga V; Nayak S; Uday Kumar JAJ; Dhar C; Sahoo PN; Sundararaj BK; Souza GD; Vyakarnam A
    PLoS Pathog; 2018 Sep; 14(9):e1007289. PubMed ID: 30231065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune checkpoint proteins (PD-L1 and CTLA-4) in endometrial carcinoma: prognostic role and correlation with CD4
    Khalifa R; Elsese N; El-Desouky K; Shaair H; Helal D
    J Immunoassay Immunochem; 2022 Mar; 43(2):192-212. PubMed ID: 34697997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequencies of PD-1- and PD-L1- positive T CD3
    Nowicka D; Grywalska E; Surdacka A; Grafka A; Roliński J
    Microb Pathog; 2019 Jan; 126():85-91. PubMed ID: 30342909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A potential new pathway for PD-L1 costimulation of the CD8-T cell response to Listeria monocytogenes infection.
    Xu D; Fu HH; Obar JJ; Park JJ; Tamada K; Yagita H; Lefrançois L
    PLoS One; 2013; 8(2):e56539. PubMed ID: 23409193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1.
    Jing CY; Fu YP; Yi Y; Zhang MX; Zheng SS; Huang JL; Gan W; Xu X; Lin JJ; Zhang J; Qiu SJ; Zhang BH
    J Immunother Cancer; 2019 Mar; 7(1):77. PubMed ID: 30885276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The PD-L1/CD86 ratio is increased in dendritic cells co-infected with porcine circovirus type 2 and porcine reproductive and respiratory syndrome virus, and the PD-L1/PD-1 axis is associated with anergy, apoptosis, and the induction of regulatory T-cells in porcine lymphocytes.
    Richmond O; Cecere TE; Erdogan E; Meng XJ; Piñeyro P; Subramaniam S; Todd SM; LeRoith T
    Vet Microbiol; 2015 Nov; 180(3-4):223-9. PubMed ID: 26446939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Small Molecule Antagonist of PD-1/PD-L1 Interactions Acts as an Immune Checkpoint Inhibitor for NSCLC and Melanoma Immunotherapy.
    Wang Y; Gu T; Tian X; Li W; Zhao R; Yang W; Gao Q; Li T; Shim JH; Zhang C; Liu K; Lee MH
    Front Immunol; 2021; 12():654463. PubMed ID: 34054817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunotyping in tubo-ovarian high-grade serous carcinoma by PD-L1 and CD8+ T-lymphocytes predicts disease-free survival.
    Bansal A; Srinivasan R; Rohilla M; Rai B; Rajwanshi A; Suri V; Chandra Saha S
    APMIS; 2021 May; 129(5):254-264. PubMed ID: 33455015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human brain endothelial cells endeavor to immunoregulate CD8 T cells via PD-1 ligand expression in multiple sclerosis.
    Pittet CL; Newcombe J; Prat A; Arbour N
    J Neuroinflammation; 2011 Nov; 8():155. PubMed ID: 22067141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PD-1 and PD-L1 Expression in Peripheral CD4/CD8+ T Cells Is Restored in the Partial Remission Phase in Type 1 Diabetes.
    Li X; Zhong T; Tang R; Wu C; Xie Y; Liu F; Zhou Z
    J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32236416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PD-L1 Overexpression in the Lungs of Subjects Who Died from COVID-19: Are We on the Way to Understanding the Immune System Exhaustion Induced by SARS-CoV-2?
    Ronchi A; Marino FZ; Carraturo E; La Mantia E; Campobasso CP; De Micco F; Mascolo P; Municinò M; Mucininò E; Vestini F; Pinto O; Moccia M; De Stefano N; Nappi O; Sementa C; Zotti G; Pianese L; Giordano C; Fico A; Franco R
    Crit Rev Eukaryot Gene Expr; 2022; 32(3):9-20. PubMed ID: 35695606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Programmed death (PD)-1 molecule and its ligand PD-L1 distribution among memory CD4 and CD8 T cell subsets in human immunodeficiency virus-1-infected individuals.
    Rosignoli G; Lim CH; Bower M; Gotch F; Imami N
    Clin Exp Immunol; 2009 Jul; 157(1):90-7. PubMed ID: 19659774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelets modulate CD4
    Paletta A; Di Diego García F; Varese A; Erra Diaz F; García J; Cisneros JC; Ludueña G; Mazzitelli I; Pisarevsky A; Cabrerizo G; López Malizia Á; Rodriguez AG; Lista N; Longueira Y; Sabatté J; Geffner J; Remes Lenicov F; Ceballos A
    Br J Haematol; 2022 May; 197(3):283-292. PubMed ID: 35076084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PD-1 modulating Mycobacterium tuberculosis-specific polarized effector memory T cells response in tuberculosis pleurisy.
    Li J; Jin C; Wu C; Huang J
    J Leukoc Biol; 2019 Sep; 106(3):733-747. PubMed ID: 30861206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia.
    Brusa D; Serra S; Coscia M; Rossi D; D'Arena G; Laurenti L; Jaksic O; Fedele G; Inghirami G; Gaidano G; Malavasi F; Deaglio S
    Haematologica; 2013 Jun; 98(6):953-63. PubMed ID: 23300177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune checkpoint expression on HIV-specific CD4+ T cells and response to their blockade are dependent on lineage and function.
    Brunet-Ratnasingham E; Morou A; Dubé M; Niessl J; Baxter AE; Tastet O; Brassard N; Ortega-Delgado G; Charlebois R; Freeman GJ; Tremblay C; Routy JP; Kaufmann DE
    EBioMedicine; 2022 Oct; 84():104254. PubMed ID: 36150362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.